3 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
Follow Emergencies: new trials by email Literature Review of Emergencies trials Research Report on Emergencies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder ED-Initiated treatment with buprenorphine / naloxone - Opioid-use Disorder | Phase 2 | Withdrawn | University of California, Davis | 2025-07-30 | 2024-11-12 | |
| Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study Spironolactone, Placebo - Acute Heart Failure | Phase 2 | Withdrawn | Indiana University | 2015-05-01 | 2017-04-21 | |
| Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam Midazolam, Chloral Hydrate - Traumatic Brain Injury, Computed Tomography | Phase 2 | Withdrawn | University of Sao Paulo | 2011-08-01 | 2013-06-20 |
Brain Injuries, Traumatic (1) · Opioid-Related Disorders (1)
Disease Attributes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Brain Diseases (1) · Brain Injuries (1) · Central Nervous System Diseases (1) · Chemically-Induced Disorders (1) · Craniocerebral Trauma (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Nervous System Diseases (1) · Substance-Related Disorders (1) · Trauma, Nervous System (1) · Wounds and Injuries (1)
Buprenorphine (1) · Buprenorphine, Naloxone Drug Combination (1) · Chloral Hydrate (1) · Midazolam (1) · Naloxone (1) · Spironolactone (1)
Indiana University (1) · University of California, Davis (1) · University of Sao Paulo (1)
Brazil (1)